Australia’s drug regulator, the Therapeutic Goods Administration (TGA), has added two new safety warnings about mental health and contraception for people taking weightloss drugs.

The TGA said that suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists and, despite no proven causal association, they feel awareness and caution is needed. 

Australian correspondent Murray Olds told Heather du Plessis-Allan, "There's still not a lot of information available. (Ozempic) hasn't been around long enough."

LISTEN ABOVE